BlueCrest Capital Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

BlueCrest Capital Management’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-100,623	Closed	-$533K	–	1268
2019 Q1	$533K	Buy	100,623 +51,837	+106%	+$237K	0.02%	461
2018 Q4	$181K	Buy	+48,786	New	+$171K	0.01%	673
2018 Q1	–	Sell	-68,142	Closed	-$201K	–	1735
2017 Q4	$201K	Buy	+68,142	New	+$188K	0.01%	715
2016 Q1	–	Sell	-72,454	Closed	-$347K	–	1326
2015 Q4	$347K	Buy	+72,454	New	+$411K	0.01%	689

Other funds holding BDSI

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

BlueCrest Capital Management's BDSI Position: Q2 2019 in Review

BlueCrest Capital Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q2 2019, closing a stake of 100,623 shares — an estimated $533K sold.

BlueCrest Capital Management first reported a position in BDSI in Q4 2015 and held it in 4 quarters. The position peaked at $533K in Q1 2019. 110 funds tracked by Wall St. Rank hold BDSI as of Q2 2019.

BlueCrest Capital Management reported no remaining BioDelivery Sciences International, Inc. position as of Q2 2019 after selling out during the quarter.
BlueCrest Capital Management sold 100,623 BioDelivery Sciences International, Inc. shares in Q2 2019, an estimated $533K.
BlueCrest Capital Management first reported a position in BioDelivery Sciences International, Inc. in Q4 2015 and held it in 4 quarters.
BlueCrest Capital Management's BioDelivery Sciences International, Inc. position peaked at $533K in Q1 2019.
110 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q2 2019.

Based on BlueCrest Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.